Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126


Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.

Huang SP, Lévesque E, Guillemette C, Yu CC, Huang CY, Lin VC, Chung IC, Chen LC, Laverdière I, Lacombe L, Fradet Y, Chang TY, Lee HZ, Juang SH, Bao BY.

Int J Cancer. 2014 Dec 1;135(11):2661-7. doi: 10.1002/ijc.28904. Epub 2014 Apr 22.


SRD5A polymorphisms and biochemical failure after radical prostatectomy.

Audet-Walsh E, Bellemare J, Nadeau G, Lacombe L, Fradet Y, Fradet V, Huang SP, Bao BY, Douville P, Girard H, Guillemette C, Lévesque E.

Eur Urol. 2011 Dec;60(6):1226-34. doi: 10.1016/j.eururo.2011.06.020. Epub 2011 Jun 29.


A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.

Cullen J, Rosner IL, Brand TC, Zhang N, Tsiatis AC, Moncur J, Ali A, Chen Y, Knezevic D, Maddala T, Lawrence HJ, Febbo PG, Srivastava S, Sesterhenn IA, McLeod DG.

Eur Urol. 2015 Jul;68(1):123-31. doi: 10.1016/j.eururo.2014.11.030. Epub 2014 Nov 29.


A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer.

Gu C, Qu Y, Zhang G, Sun L, Zhu Y, Ye D.

Oncotarget. 2015 Oct 13;6(31):32205-11. doi: 10.18632/oncotarget.4980.


Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.

Huang CY, Huang SP, Lin VC, Yu CC, Chang TY, Juang SH, Bao BY.

Sci Rep. 2015 Feb 24;5:8556. doi: 10.1038/srep08556.


Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.

Chen CS, Huang CY, Huang SP, Lin VC, Yu CC, Chang TY, Bao BY.

Int J Med Sci. 2015 Feb 5;12(3):243-7. doi: 10.7150/ijms.10953. eCollection 2015.


Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.

Huang SP, Huang LC, Ting WC, Chen LM, Chang TY, Lu TL, Lan YH, Liu CC, Yang WH, Lee HZ, Hsieh CJ, Bao BY.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3068-74. doi: 10.1158/1055-9965.EPI-09-0665.


The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.

Laverdière I, Flageole C, Audet-Walsh É, Caron P, Fradet Y, Lacombe L, Lévesque É, Guillemette C.

Endocr Relat Cancer. 2015 Feb;22(1):77-85. doi: 10.1530/ERC-14-0423. Epub 2014 Dec 1.


Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.

Yu CC, Lin VC, Huang CY, Liu CC, Wang JS, Wu TT, Pu YS, Huang CH, Huang CN, Huang SP, Bao BY.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S492-9. doi: 10.1245/s10434-013-2869-x. Epub 2013 Jan 26.


Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.

Cooperberg MR, Davicioni E, Crisan A, Jenkins RB, Ghadessi M, Karnes RJ.

Eur Urol. 2015 Feb;67(2):326-33. doi: 10.1016/j.eururo.2014.05.039. Epub 2014 Jul 2.


Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.

Li T, Gui Y, Yuan T, Liao G, Bian C, Jiang Q, Huang S, Liu B, Wu D.

BJU Int. 2012 Dec;110(11 Pt C):E1125-30. doi: 10.1111/j.1464-410X.2012.11277.x. Epub 2012 Jun 6.


The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.

Audet-Walsh É, Bellemare J, Lacombe L, Fradet Y, Fradet V, Douville P, Guillemette C, Lévesque É.

Eur Urol. 2012 Jul;62(1):88-96. doi: 10.1016/j.eururo.2011.12.021. Epub 2011 Dec 21.


Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.

Gu C, Li Q, Zhu Y, Qu Y, Zhang G, Wang M, Yang Y, Wang J, Jin L, Wei Q, Ye D.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):310-6. doi: 10.1038/pcan.2015.27. Epub 2015 Aug 4.


Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.

Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.

Clin Cancer Res. 2005 Dec 1;11(23):8321-5.


Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.

Melbø-Jørgensen C, Ness N, Andersen S, Valkov A, Dønnem T, Al-Saad S, Kiselev Y, Berg T, Nordby Y, Bremnes RM, Busund LT, Richardsen E.

PLoS One. 2014 Nov 17;9(11):e113039. doi: 10.1371/journal.pone.0113039. eCollection 2014.


Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.

Oh JJ, Park S, Lee SE, Hong SK, Lee S, Lee HM, Lee JK, Ho JN, Yoon S, Byun SS.

J Cancer Res Clin Oncol. 2015 Aug;141(8):1493-501. doi: 10.1007/s00432-015-1947-9. Epub 2015 Mar 13.


Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy.

Cotignola J, Leonardi DB, Shahabi A, Acuña AD, Stern MC, Navone N, Scorticati C, De Siervi A, Mazza O, Vazquez E.

Prostate Cancer Prostatic Dis. 2013 Mar;16(1):28-34. doi: 10.1038/pcan.2012.45. Epub 2012 Nov 13.


Genetic predisposition to early recurrence in clinically localized prostate cancer.

Borque Á, del Amo J, Esteban LM, Ars E, Hernández C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventós CX, Tejedor D, Artieda M, Simon L, Martínez A, Carceller E, Suárez M, Allué M, Sanz G, Morote J.

BJU Int. 2013 Apr;111(4):549-58. doi: 10.1111/j.1464-410X.2012.11333.x. Epub 2012 Jul 3.


Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy.

Long Q, Johnson BA, Osunkoya AO, Lai YH, Zhou W, Abramovitz M, Xia M, Bouzyk MB, Nam RK, Sugar L, Stanimirovic A, Williams DJ, Leyland-Jones BR, Seth AK, Petros JA, Moreno CS.

Am J Pathol. 2011 Jul;179(1):46-54. doi: 10.1016/j.ajpath.2011.03.008. Epub 2011 May 3.


Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.

Kang M, Jeong CW, Ku JH, Kwak C, Kim HH.

PLoS One. 2015 Mar 24;10(3):e0122438. doi: 10.1371/journal.pone.0122438. eCollection 2015.

Items per page

Supplemental Content

Write to the Help Desk